title: Major malformations in infants of IDDM women. Vasculopathy and early first-trimester poor glycemic control.
abstract: From animal and in vitro studies, it has been suggested that high environmental glucose, ketone, or insulin concentrations and low glucose or insulin concentrations may be etiologic factors for congenital malformations (CMs) in infants of diabetic mothers (IDMs). Transplacental passage of antibody-bound insulin has been demonstrated in humans. Controversy exists regarding the pathophysiology of CMs in human insulin-dependent diabetes mellitus (IDDM) pregnancies. We hypothesized that CMs in IDMs are associated with maternal vasculopathy, poor first-trimester glycemic control (i.e., hyper- and/or hypoglycemia), advanced White class, and high insulin requirements. We studied 165 first pregnancies of women with IDDM from 1978 to 1986. The goals of glucose control were a fasting blood glucose of less than 100 mg/dl and a 90-min postprandial blood glucose of less than 140 mg/dl. Insulin requirements, body weight, and pre- and postprandial blood glucose were recorded at weekly clinic visits. Maternal blood HbA1 was measured on entry and every 4 wk to confirm that adequate glycemic control was achieved. Women who enrolled in the project were interviewed during gestation by a geneticist/dysmorphologist who obtained genetic and environmental histories using a standard questionnaire. All live-born infants and stillbirths were examined. Each live-born infant was assessed systematically by two independent examiners, a neonatologist and a geneticist/dysmorphologist; examination with standardized checklists was performed in the newborn nursery as soon after birth as was practical. In first pregnancies in the study, there were 13 IDMs with major CMs (7.9%).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Ohio 45267-0526.
authors.forename: M
authors.initials: M
authors.lastname: Miodovnik
authors.forename: F
authors.initials: F
authors.lastname: Mimouni
authors.forename: P S
authors.initials: PS
authors.lastname: Dignan
authors.forename: M A
authors.initials: MA
authors.lastname: Berk
authors.forename: J L
authors.initials: JL
authors.lastname: Ballard
authors.forename: T A
authors.initials: TA
authors.lastname: Siddiqi
authors.forename: J
authors.initials: J
authors.lastname: Khoury
authors.forename: R C
authors.initials: RC
authors.lastname: Tsang
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D000013:Congenital Abnormalities / Q000453:epidemiology / Q000209:etiology*; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011254:Pregnancy in Diabetics / Q000503:physiopathology*
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin